Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.76M Sell
4,186
-1,447
-26% -$577K 0.76% 55
2026
Q2
$2.04M Buy
5,633
+33
+0.6% +$11.3K 0.93% 47
2026
Q1
$1.97M Buy
5,600
+10
+0.2% +$3.56K 1.05% 47
2025
Q4
$1.83M Sell
5,590
-260
-4% -$82.5K 0.98% 45
2025
Q3
$1.65M Buy
5,850
+126
+2% +$36.5K 0.89% 49
2025
Q2
$1.6M Buy
5,724
+276
+5% +$78.2K 0.92% 53
2025
Q1
$1.7M Sell
5,448
-145
-3% -$42.8K 1.1% 41
2024
Q4
$1.46M Buy
5,593
+910
+19% +$270K 0.88% 51
2024
Q3
$1.51M Sell
4,683
-185
-4% -$60.5K 0.93% 45
2024
Q2
$1.52M Buy
4,868
+6
+0.1% +$1.76K 0.98% 38
2024
Q1
$1.38M Sell
4,862
-67
-1% -$19.6K 0.93% 48
2023
Q4
$1.42M Buy
+4,929
New +$1.34M 1.02% 40

Other funds holding AMGN

Boomfish Wealth Group's AMGN Position: Q3 2026 in Review

Boomfish Wealth Group reduced its Amgen (AMGN) stake by 26% in Q3 2026, selling an estimated $577K and leaving 4,186 shares worth $1.76M. The position accounts for 0.76% of the portfolio, ranked #55.

Boomfish Wealth Group first reported a position in AMGN in Q4 2023 and has held it in 12 quarters since. The position peaked at $2.04M in Q2 2026. 2,268 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Boomfish Wealth Group held 4,186 shares of Amgen worth $1.76M as of Q3 2026.
  • Boomfish Wealth Group sold 1,447 Amgen shares in Q3 2026, an estimated $577K.
  • Amgen made up 0.76% of Boomfish Wealth Group's portfolio in Q3 2026, its #55 holding.
  • Boomfish Wealth Group first reported a position in Amgen in Q4 2023 and has held it in 12 quarters since.
  • Boomfish Wealth Group's Amgen position peaked at $2.04M in Q2 2026.
  • 2,268 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Boomfish Wealth Group's 13F filing for Q3 2026, filed 22 Oct 2026.